1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. ZYDUS LIFESCIENCES LTD.

Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321

Mid-range Performer
Download real time

928.00 -2.00 (-0.22%)

29.93% Fall from 52W High

961.4K NSE+BSE Volume

NSE 02 Jun, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Share
17S
3W
3O
5T
93,378.5

Market Cap

High in industry
20.3

PE TTM

Below industry Median
1.2

PEG TTM

PEG TTM is much higher than 1
4.3

Price to Book

Above industry Median
0.7

Beta 1Year

Very Low volatility
US FDA Approval
Zydus Lifesciences gets US FDA approval for Rifaximin tablets with a market size of $2.6 bn See details

Zydus Lifesciences Ltd. - ZYDUSLIFE - stock price prediction, stock forecast, target price, analyst ratings from 32 analysts

Zydus Lifesciences Ltd. has a share price target of Rs 986, revenue growth forecast of 7.6%, and profit growth estimate of 0.3% for FY26, based on top 32 analyst calls.

Forecaster Screeners